KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Free Cash Flow (2018 - 2026)

Moderna (MRNA) has disclosed Free Cash Flow for 9 consecutive years, with -$665.0 million as the latest value for Q1 2026.

  • For Q1 2026, Free Cash Flow rose 38.82% year-over-year to -$665.0 million; the TTM value through Mar 2026 reached -$1.6 billion, up 59.55%, while the annual FY2025 figure was -$2.1 billion, 49.08% up from the prior year.
  • Free Cash Flow hit -$665.0 million in Q1 2026 for Moderna, down from $780.0 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $2.6 billion in Q1 2022 and bottomed at -$2.0 billion in Q3 2024.
  • Average Free Cash Flow over 5 years is -$354.6 million, with a median of -$769.0 million recorded in 2025.
  • Year-over-year, Free Cash Flow tumbled 636.41% in 2023 and then surged 380.95% in 2024.
  • Moderna's Free Cash Flow stood at $1.3 billion in 2022, then plummeted by 95.31% to $63.0 million in 2023, then soared by 380.95% to $303.0 million in 2024, then soared by 157.43% to $780.0 million in 2025, then plummeted by 185.26% to -$665.0 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$665.0 million, $780.0 million, and -$769.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.